Diabetes Drug Eyed as Obesity TreatmentDiabetes Drug Eyed as Obesity Treatment
Already approved for the treatment of diabetes, the incretin mimetic liraglutide is now being investigated as a potential weight-loss drug. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | Health | Incretin Therapy | Obesity | Victoza | Weight Loss